Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.65    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.05 (1.075%)
Market Cap: £223.18m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

Directorate Changes

3 Jan 2012 07:00

RNS Number : 8382U
Seeing Machines Limited
03 January 2012
 



 

3 January 2012

Seeing Machines Limited

 

("Seeing Machines" or the "Company")

 

Directorate Changes

 

Seeing Machines Limited (AIM: SEE), a leading developer of facial image processing software for applications that rely on understanding the movement of human faces and eyes, announces today the appointment of Kenneth (Ken) Kroeger to the board of Seeing Machines as Managing Director and the resignation of past Chairman William (Bill) Mobbs as a director of the Company. Mr Mobbs resignation takes effect from the 31st of December 2011 and Mr Kroeger's appointment is with immediate effect.

 

Bill Mobbs who joined the board of the Company in 2006 and took over as Chairman in 2009 leaves the board to concentrate on his other business interests.

 

Ken Kroeger, aged 50, is a successful technology entrepreneur who founded Catalyst Interactive, an internationally recognised 3-D simulation and training provider (later acquired by KBR). At Catalyst Interactive, Ken grew the organisation from inception to an international business through technical innovation and sound leadership.

 

Ken's background in technology, research and development, business management and sales has provided Seeing Machines with a strong commercial focus since his appointment as CEO in July 2011.

 

David Gaul, the current Chairman of the Company commented:

 

"The Company is delighted that Ken has joined the board and the directors are already aware that he brings a wealth of industry knowledge and experience which will prove invaluable to Seeing Machines. The Company wishes to express its sincere thanks to Bill Mobbs for his significant contribution to the Company over the last 5 years."

 

Save for the above, the following information, pursuant to AIM Rule 17, Schedule Two (g) is disclosed in respect of the appointment of Ken:

 

Current Appointments:

Travelok Pty LtdHealthcube Management Pty LtdHealthcube Pty LtdKroeger Nominees Pty LtdLighthouse Business Innovation Centre LimitedConnexions Pty LtdContact Action Pty LtdInsperience Pty Ltd

Past Appointments:

Catalyst Interactive Pty LtdEqual Access Testing Pty Ltd

Mr Kroeger is not currently interested in the total issued share capital of the Company.

 

 

 

 

Enquiries:

 

Seeing Machines Limited

Ken Kroeger, Managing Director & CEO

+61 (0) 2 6103 4700

 

Daniel Stewart & Company plc(Nomad & Broker)

David Hart/James Thomas

+44 (0) 20 7776 6550

 

Walbrook PR Ltd

+44 (0) 20 7933 8780

Bob Huxford

bob.huxford@walbrookpr.com

Helen Westaway

helen.westaway@walbrookpr.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUGUMAGUPPGUP
Date   Source Headline
12th May 20267:00 amRNSUS$3.8m Order for Guardian BdMS
6th May 20267:00 amRNSQ3 FY2026 Quarterly KPIs
20th Apr 202612:30 pmRNSHolding(s) in Company
10th Apr 20268:53 amRNSStatement re alleged cyber threat
27th Mar 20267:00 amRNSHalf-year Financial Report
24th Feb 20267:00 amRNS-RPublication of Investor Presentation
18th Feb 20267:00 amRNSTrading Update - H1 FY2026
13th Feb 20267:30 amRNSAppointment of Joint Broker
11th Feb 20267:00 amRNSQ2 FY2026 Quarterly KPIs
13th Jan 202612:00 pmRNS-R3D Cabin Perception Mapping breaks new ground
6th Jan 20267:00 amRNSAgreement
5th Jan 20267:00 amRNS-R3D Cabin Perception Mapping to be unveiled at CES
5th Jan 20267:00 amRNSHolding(s) in Company
2nd Jan 20267:00 amRNS-RSeeing Machines Announces Future Mobility Group
2nd Jan 20267:00 amRNS-RSeeing Machines Announces Future Mobility Group
17th Dec 20257:00 amRNS-RTechnical Paper Series - Intoxication launched
4th Dec 20257:00 amRNS-RSeeing Machines 2025 Guardian Insights Report
27th Nov 20257:00 amRNSResults of AGM
26th Nov 20257:30 amRNSJapanese Auto Award and Extended European Program
12th Nov 20257:05 amRNSQ1 FY2026 Quarterly KPIs
12th Nov 20257:00 amRNSGuardian order from US-based multinational company
6th Nov 20257:05 amRNS-RCollaboration with Magna milestone in China
3rd Nov 20257:00 amRNSBoard Changes
3rd Nov 20257:00 amRNSNotice of Annual General Meeting
30th Oct 20257:00 amRNSLATAM Distributor Orders 1,300 Guardian Units
29th Oct 20257:00 amRNSAdvanced Development Project with Japanese OEM
8th Oct 20257:00 amRNSUS$1.8m expansion order for Guardian BdMS
26th Sep 20257:00 amRNSExpanding Guardian prospects across Europe
25th Sep 20257:00 amRNSFY2025 Results and Annual Financial Report
24th Sep 20257:20 amRNSFirst Guardian contract through Mitsubishi
10th Sep 20257:05 amRNS-RSeeing Machines Launches Impairment Capability
10th Sep 20257:00 amRNSNotice of Results and Presentation
29th Aug 202510:10 amRNSDirector Dealing
21st Aug 20257:00 amRNSFY2025 Trading Update
5th Aug 20257:00 amRNSQ4 FY2025 Quarterly KPIs
30th Jun 20257:00 amRNSMitsubishi Electric Europe Guardian collaboration
27th Jun 20257:00 amRNSUS Guardian Gen 3 trial with Mitsubishi Electric
16th Jun 20258:59 amRNS$1.2 Million Agreement with Global Auto Leader
9th May 20252:31 pmRNSDirector dealing
1st May 20257:00 amRNSQ3 FY2025 Quarterly KPIs
29th Apr 20259:58 amRNSNotification of Major Holdings
8th Apr 20258:53 amRNSHoldings in Company
8th Apr 20257:00 amRNSDirector/PDMR Shareholding
4th Apr 20257:00 amRNSDirector dealing
2nd Apr 202511:00 amRNSLondon presentation for investors and analysts
2nd Apr 20257:00 amRNSDirector dealing
2nd Apr 20257:00 amRNSDirector dealing
1st Apr 202512:00 pmRNS-RSeeing Machines Announces 3D Camera Technology
31st Mar 20257:00 amRNSDirector/PDMR Shareholding
28th Mar 20257:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.